Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders.
Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain.
By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain.
By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
Location: France, Ile-de-France
Employees: 1-10
Total raised: $64.82M
Founded date: 2010
Investors 3
Funding Rounds 5
| Date | Series | Amount | Investors |
| 12.12.2023 | Series B | $4.86M | - |
| 27.06.2023 | Series B | $41.07M | - |
| 14.09.2020 | Grant | $2.37M | - |
| 12.12.2018 | Series B | $10.23M | - |
| 12.10.2016 | - | $6.28M | - |
Mentions in press and media 10
| Date | Title | Description |
| 12.12.2023 | Carthera secures additional €4.5M for innovative medtech to treat brain disorders | This week, medtech company Carthera, a spin-off from Sorbonne University, announced an additional €4.5 million in funding to complement its Series B financing round, bringing the total raised to €42 million. Carthera is a clinical-stage med... |
| 11.12.2023 | Carthera Raises Additional €4.5M; Brings Series B round to €42M | Carthera, a Paris, France-based clinical-stage medtech company, raised additional €4.5M in funding. The round, which brought the total amount of Series B to €42M, saw participation from Unorthodox Ventures, with participation from Supernova... |
| 27.06.2023 | Carthera Closes €37.5M Series B Funding | Carthera, a Lyon and Paris, France-based developer of an ultrasound-based medical device, raised €37.5M in Series B funding. The round was led by an undisclosed investor, alongside the European Innovation Council Fund (EICF), Panakès Partne... |
| 14.09.2020 | CarThera to receive €2M grant and €10.5M equity from the European Innovation Council | CarThera to receive €2M grant and €10.5M equity from the European Innovation Council CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that it has been... |
| 12.12.2018 | Daily funding roundup - December 12th, 2018 | AVOXI raised $10M; Zesty.ai raised $13M; 4iQis raised $20M; Juniper Square raised $25M Inscribe: Inscribe helps companies detect fraudulent documents so they can trust their customers and grow faster. Inscribe has raised $3 million in fundi... |
| 12.12.2018 | CarThera closes €9M ($10.3M) Series B funding round | CarThera closes €9M ($10.3M) Series B funding round Funding will enable company to launch multi-center trial in patients with recurrent glioblastoma and develop clinical pipeline Paris, France, December 12, 2018 – CarThera, a French company... |
| 12.12.2018 | CarThera Closes €9M Series B Funding | CarThera, a Paris, France-based company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, closed its €9M ($10.3M) Series B funding round. Backers included Panakès Partners, Sham Innovation Santé... |
| 12.12.2018 | Term Sheet — Wednesday, December 12 | A YEAR OF MEGA-DEALS Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop “Through a fog of uncertainty, IPO markets around the world found a clear path forward and investment opportunities... |
| 12.10.2016 | CarThera Secures €5.7M in Funding | CarThera, a Paris, France-based developer of medical devices to treat brain disorders, received a grant of €5.7m ($6.4m). The funding was awarded under the call for proposals ‘Structuring R&D Projects for Competitiveness’ from France’s ... |
| - | CarThera | “Revolutionizing severe brain disease treatments” |